Mason-Pfizer Monkey Retroviral packaging defective vectors
US5747307A · kind A · utility
16Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 26, 1994 |
| Grant date | May 5, 1998 |
| Priority date | — |
| Expiry date | Aug 26, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16222
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel vectors are capable of producing MPMV (Mason-Pfizer Monkey Virus) proteins but not of packaging MPMV RNA, and the information about the packaging signal in MPMV and HIV can be used to create MPMV and HIV vectors that are capable of transferring foreign genes, e.g. for use in gene therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.